In 2012, Abdollahpour et al. reported a homozygous premature termination mutation of MST1 with a novel clinical phenotype including T- and B-cell lymphopenia, intermittent neutropenia, and atrial septal defects; this suggest that MST1 deficiency is a novel human primary immunodeficiency syndrome. This evidence concerns the gene MST1 and neutropenia.